PRL3-zumab as an immunotherapy to inhibit tumors expressing PRL3 oncoprotein

• Main Authors: Thura M., Al-Aidaroos A.Q., Gupta A., Chee C.E., Lee S.C., Hui K.M., Li J., Guan Y.K., Yong W.P., So J., Chng W.J., Ng C.H., Zhou J., Wang L.Z., Yuen J.S.P., Ho H.S.S., Yi S.M., Chiong E., Choo S.P., Ngeow J., Ng M.C.H., Chua C., Yeo E.S.A., Tan I.B.H., Sng J.X.E., Tan N.Y.Z., Thiery J.P., Goh B.C., Zeng Q.
• 其他作者: PHARMACOLOGY
• 格式: Article
• 出版: Nature Publishing Group 2020
• 在線閱讀: https://scholarbank.nus.edu.sg/handle/10635/175940

10.1038/s41467-019-10127-x